Inventor · name-matched record
HE FENG
3 granted patents·2 pending applications·0 citations·filing 2019–2023
37Inventor score
Files withJIANGSU HENGRUI PHARMACEUTICALS CO LTD2HC BIOPHARMA SHANGHAI CO LTD1JIANGSU HENGRUI MEDICINE CO1KYINNO BIOTECHNOLOGY CO LTD1
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
5 records- 0165US2026055088A1Heterocyclic compound, method for preparing same, and pharmaceutical use thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0258US2026085114A1Anti-gprc5d antibody and use thereofKYINNO BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0354US12590081B2Fused imidazole derivatives, preparation method and medicinal use thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2021·Granted Mar 31, 2026·0 cites·21 claims
- 0449US12559488B2Substituted morpholines as ATR kinase inhibitorsJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Feb 24, 2026·0 cites·18 claims
- 0537US12516123B2Anti-PD-L1 antibody and pharmaceutical use thereofHC BIOPHARMA SHANGHAI CO LTD·Filed 2019·Granted Jan 6, 2026·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when HE FENG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →